Physician profile
George V Cioffi
NPI 1578529343
$3,356.97
in general payments reported to CMS, 2019-2025
9 companies · $48.16 in 2025
The $48.16 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,108 · 2022: $833 · 2023: $1,012 · 2024: $356 · 2025: $48.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,322.53 | 2021-2024 | |
| Lundbeck LLC | $773.28 | 2021-2024 | Rexulti, Vyepti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $452.43 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $258.53 | 2021-2024 | Rexulti |
| Almatica Pharma LLC | $235.06 | 2021-2024 | Loreev Xr, Sertraline Hcl, Venlafaxine |
| Sunovion Pharmaceuticals INC. | $189.83 | 2021-2022 | |
| Tris Pharma INC | $63.55 | 2024 | Dyanavel Xr |
| Vanda Pharmaceuticals INC. | $34.32 | 2023 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $27.44 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Cioffi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.